Continued challenges related to vaccine-preventable diseases
Monday, July 12, 2021
10. Immunology & vaccinology, 1,5-hour Symposium
10c. General vaccinology (incl. policy, social aspects)
•
2519
•
3:30 PM
>
5:00 PM
•
Continued challenges related to vaccine-preventable diseases
•
10. Immunology & vaccinology
10c. General vaccinology (incl. policy, social aspects)
Vaccination uptake remains under the targeted threshold required for protection against many vaccine-preventable diseases in Europe. For measles, vaccination coverage needs to be above 95% in order to stop transmission at population level. The re-emergence of large epidemics of measles in the past 10 years in the European continent exemplifies how important keeping up coverage is, and how increasing vaccine hesitancy and globalisation of lifestyles can yield a low level of protection of populations. In parallel, advances in the understanding of vaccine hesitancy have been huge. As the vaccination programmes, their funding bases and surveillance systems of vaccine preventable diseases and vaccinations in the EU countries differ, solutions to overcome these barriers need to be tailored according to best evidence. In this session, the evidence base of reluctance to vaccinate and measures to overcome these hurdles as well as measuring the impact are being explored with real world examples.
3:30 PM
•
2519-1
•
Measles pathogenesis and immune suppression: lessons from animal models and clinical studies
>
R.
Rik
DE SWART (Rotterdam)
3:50 PM
•
2519-2
•
Measles: a model of under coverage and its consequences
>
L.
Lucia
PASTORE CELENTANO (Stockholm)
4:10 PM
•
2519-3
•
The IRIS Initiative reveals significant reductions in invasive bacterial diseases during the COVID-19 pandemic
>
A.
Angela
BRUEGGEMANN (Oxford)
4:30 PM
•
2519-4
•
Promoting equity in vaccine coverage
>
E.
Ed
CLARKE (Banjul)
4:50 PM
•
2519-5
•
Q&A/Discussion
|